BioMark Diagnostics Inc., providing universal access to cancer diagnostics and early stage detection by leveraging the power of new technology.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
BioMark Raman SenSers Product Launch at Strategies on Biophotonics Boston September 9-11 2014 http://pubs.rsc.org/en/Content/ArticleLanding/2014/AN/c4an01309c#!divAbstract BioMark
For more information, visit Optics Infobase: http://www.opticsinfobase.org/boe/abstract.cfm?uri=boe-5-12-4101 Or download the following PDF: boe-5-12-4101
BioMark is actively pursuing international business and research collaborations to increase its global footprint. North
Clinical Trial and Gene Expression Ethics Approval BioMark has received conditional approval from the University
NRC – IRAP Funding for 2013 – BioMark will be funded generously by NRC with
Going Global completed two visits to China and signed a collaboration agreement with Dr. Liu
– BioMark successfully generated 3 monoclonal antibody against the molecule of interest. This is a
MITACS Accelerate Program – BioMark has applied for 3 major programs under Mitacs at UBC
BioMark has recently completed a very encouraging metabolome study that has implication for biomarker signature
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2
Rashid A. Bux (CEO)
[email protected]